-
1
-
-
76449093190
-
Update on procedure-related risks for prenatal diagnosis techniques
-
A. Tabor, and Z. Alfirevic Update on procedure-related risks for prenatal diagnosis techniques Fetal Diagn Ther 27 2010 1 7
-
(2010)
Fetal Diagn Ther
, vol.27
, pp. 1-7
-
-
Tabor, A.1
Alfirevic, Z.2
-
2
-
-
77349102207
-
Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age
-
N. Nakata, Y. Wang, and S. Bhatt Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age Prenat Diagn 30 2010 198 206
-
(2010)
Prenat Diagn
, vol.30
, pp. 198-206
-
-
Nakata, N.1
Wang, Y.2
Bhatt, S.3
-
3
-
-
0034987147
-
Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older
-
M.A. Zoppi, R.M. Ibba, M. Putzolu, M. Floris, and G. Monni Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older Obstet Gynecol 97 2001 916 920
-
(2001)
Obstet Gynecol
, vol.97
, pp. 916-920
-
-
Zoppi, M.A.1
Ibba, R.M.2
Putzolu, M.3
Floris, M.4
Monni, G.5
-
5
-
-
20444493456
-
The impact of first-trimester screening on AMA patients' uptake of invasive testing
-
A.M. Wray, A. Ghidini, C. Alvis, J. Hodor, H.J. Landy, and S.H. Poggi The impact of first-trimester screening on AMA patients' uptake of invasive testing Prenat Diagn 25 2005 350 353
-
(2005)
Prenat Diagn
, vol.25
, pp. 350-353
-
-
Wray, A.M.1
Ghidini, A.2
Alvis, C.3
Hodor, J.4
Landy, H.J.5
Poggi, S.H.6
-
6
-
-
80755172331
-
DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
-
G.E. Palomaki, E.M. Kloza, and G.M. Lambert-Messerlian DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
-
(2011)
Genet Med
, vol.13
, pp. 913-920
-
-
Palomaki, G.E.1
Kloza, E.M.2
Lambert-Messerlian, G.M.3
-
7
-
-
84857868297
-
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study
-
G.E. Palomaki, C. Deciu, and E.M. Kloza DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study Genet Med 14 2012 296 305
-
(2012)
Genet Med
, vol.14
, pp. 296-305
-
-
Palomaki, G.E.1
Deciu, C.2
Kloza, E.M.3
-
8
-
-
84860213983
-
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing
-
D.W. Bianchi, L.D. Platt, and J.D. Goldberg Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing Obstet Gynecol 119 2012 890 901
-
(2012)
Obstet Gynecol
, vol.119
, pp. 890-901
-
-
Bianchi, D.W.1
Platt, L.D.2
Goldberg, J.D.3
-
9
-
-
84864408781
-
Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
-
M.E. Norton, H. Brar, and J. Weiss Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 Am J Obstet Gynecol 207 2012 137.e1 137.e8
-
(2012)
Am J Obstet Gynecol
, vol.207
, pp. 137e1-137e8
-
-
Norton, M.E.1
Brar, H.2
Weiss, J.3
-
10
-
-
84870688045
-
Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors
-
S. Dan, W. Wang, and J. Ren Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors Prenat Diagn 32 2012 1225 1232
-
(2012)
Prenat Diagn
, vol.32
, pp. 1225-1232
-
-
Dan, S.1
Wang, W.2
Ren, J.3
-
11
-
-
84862776853
-
Prenatal detection of down syndrome using massively parallel sequencing (MPS): A rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011
-
P. Benn, A. Borrell, and H. Cuckle Prenatal detection of down syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 Prenat Diagn 32 2012 1 2
-
(2012)
Prenat Diagn
, vol.32
, pp. 1-2
-
-
Benn, P.1
Borrell, A.2
Cuckle, H.3
-
12
-
-
84880045096
-
Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis
-
P. Benn, A. Borell, and R. Chiu Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis Prenat Diagn 33 2013 622 629
-
(2013)
Prenat Diagn
, vol.33
, pp. 622-629
-
-
Benn, P.1
Borell, A.2
Chiu, R.3
-
13
-
-
84877926367
-
Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the National Society of Genetic Counselors
-
P.L. Devers, A. Cronister, K.E. Ormond, F. Facio, C.K. Brasington, and P. Flodman Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors J Genet Counsel 22 2013 291 295
-
(2013)
J Genet Counsel
, vol.22
, pp. 291-295
-
-
Devers, P.L.1
Cronister, A.2
Ormond, K.E.3
Facio, F.4
Brasington, C.K.5
Flodman, P.6
-
14
-
-
84870156368
-
American College of Obstetricians and Gynecologists Committee on Genetics Committee Opinion no. 545. Noninvasive prenatal testing for fetal aneuploidy
-
American College of Obstetricians and Gynecologists
-
American College of Obstetricians and Gynecologists American College of Obstetricians and Gynecologists Committee on Genetics Committee Opinion no. 545. Noninvasive prenatal testing for fetal aneuploidy Obstet Gynecol 120 2012 1532 1534
-
(2012)
Obstet Gynecol
, vol.120
, pp. 1532-1534
-
-
-
15
-
-
84877253478
-
ACMG statement on noninvasive prenatal screening for fetal aneuploidy
-
A.R. Gregg, S.J. Gross, and R.G. Best ACMG statement on noninvasive prenatal screening for fetal aneuploidy Genet Med 15 2013 395 398
-
(2013)
Genet Med
, vol.15
, pp. 395-398
-
-
Gregg, A.R.1
Gross, S.J.2
Best, R.G.3
-
16
-
-
84907687059
-
555: The impact of noninvasive prenatal testing on the practice of maternal fetal medicine
-
L. Friel, J. Czerwinski, and C. Singletary 555: The impact of noninvasive prenatal testing on the practice of maternal fetal medicine Am J Obstet Gynecol 208 2013 S238
-
(2013)
Am J Obstet Gynecol
, vol.208
, pp. 238
-
-
Friel, L.1
Czerwinski, J.2
Singletary, C.3
-
17
-
-
84878125815
-
Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
-
S. Chetty, M.J. Garabedian, and M.E. Norton Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening Prenat Diagn 33 2013 542 546
-
(2013)
Prenat Diagn
, vol.33
, pp. 542-546
-
-
Chetty, S.1
Garabedian, M.J.2
Norton, M.E.3
-
18
-
-
84878120833
-
Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples
-
T. Futch, J. Spinosa, S. Bhatt, E. De Feo, R.P. Rava, and A.J. Sehnert Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples Prenat Diagn 33 2013 569 574
-
(2013)
Prenat Diagn
, vol.33
, pp. 569-574
-
-
Futch, T.1
Spinosa, J.2
Bhatt, S.3
De Feo, E.4
Rava, R.P.5
Sehnert, A.J.6
-
19
-
-
79959194256
-
Beyond the first trimester screen: Can we predict who will choose invasive testing?
-
S. Van Landingham, J. Bienstock, E. Wood Denne, and N. Hueppchen Beyond the first trimester screen: can we predict who will choose invasive testing? Genet Med 13 2011 539 544
-
(2011)
Genet Med
, vol.13
, pp. 539-544
-
-
Van Landingham, S.1
Bienstock, J.2
Wood Denne, E.3
Hueppchen, N.4
-
20
-
-
84879498242
-
Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies
-
M.M. Gil, M.S. Quezada, B. Bregant, M. Ferraro, and K.H. Nicolaides Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies Ultrasound Obstet Gynecol 42 2013 34 40
-
(2013)
Ultrasound Obstet Gynecol
, vol.42
, pp. 34-40
-
-
Gil, M.M.1
Quezada, M.S.2
Bregant, B.3
Ferraro, M.4
Nicolaides, K.H.5
-
21
-
-
84865127702
-
Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies
-
S.S. Garfield, and S.O. Armstrong Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies J Manag Care Med 15 2012 8
-
(2012)
J Manag Care Med
, vol.15
, pp. 8
-
-
Garfield, S.S.1
Armstrong, S.O.2
-
22
-
-
84874510427
-
The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine
-
N.C. Rose, D. Lagrave, B. Hafen, and M. Jackson The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine Prenat Diagn 33 2013 242 244
-
(2013)
Prenat Diagn
, vol.33
, pp. 242-244
-
-
Rose, N.C.1
Lagrave, D.2
Hafen, B.3
Jackson, M.4
-
23
-
-
84876270082
-
Noninvasive prenatal testing for fetal aneuploidy: Clinical assessment and a plea for restraint
-
M.E. Norton, N.C. Rose, and P. Benn Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint Obstet Gynecol 121 2013 847 850
-
(2013)
Obstet Gynecol
, vol.121
, pp. 847-850
-
-
Norton, M.E.1
Rose, N.C.2
Benn, P.3
-
24
-
-
84907680858
-
Investigation of the impact of noninvasive prenatal testing for fetal aneuploidy on utilization of prenatal diagnostic procedures and pregnant women's views
-
Verinata Health, Inc., an Illumina Company National Library of Medicine (US) Bethesda, MD Available at: Accessed Jan. 14, 2014
-
Verinata Health, Inc., an Illumina Company Investigation of the impact of noninvasive prenatal testing for fetal aneuploidy on utilization of prenatal diagnostic procedures and pregnant women's views ClinicalTrials.gov [Internet] 2000 National Library of Medicine (US) Bethesda, MD Available at: http://clinicaltrials.gov/ct2/show/NCT01708746 Accessed Jan. 14, 2014
-
(2000)
ClinicalTrials.gov [Internet]
-
-
|